Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. - Wikidata - awgldk - TriplyDB

Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.

Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.

http://www.wikidata.org/entity/Q45201786

about

Contrast Medium-Induced Acute Kidney Injury Hemodynamic and tubular changes induced by contrast media Clinical usefulness of urinary liver-type fatty-acid-binding protein as a perioperative marker of acute kidney injury in patients undergoing endovascular or open-abdominal aortic aneurysm repair Early renal dysfunction after contrast media administration despite prophylactic hydration Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology.Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy.Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies.Contrast induced nephropathy in urology.Periprocedural hemoglobin drop and contrast-induced nephropathy in percutaneous coronary intervention patients.Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience.Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry Development of contrast-induced acute kidney injury after elective contrast media exposure in patients with type 2 diabetes mellitus: effect of albuminuria.Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced Nephropathy Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention.Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.Compound danshen dripping pill pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention.Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction.Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: a retrospective cohort study Determination of safe contrast media dosage to estimated glomerular filtration rate ratios to avoid contrast-induced nephropathy after elective percutaneous coronary intervention.The importance of contrast volume/glomerular filtration rate ratio in contrast-induced nephropathy patients after transcatheter aortic valve implantation Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy.Contrast-induced nephropathy in interventional cardiology Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback.The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.Safe contrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention.Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography.Remote Ischemic Preconditioning for the Prevention of Contrast-Induced Acute Kidney Injury in Diabetics Receiving Elective Percutaneous Coronary Intervention The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry.Comparison of the efficacy of recombinant human brain natriuretic peptide with saline hydration in preventing contrast-induced nephropathy in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention Risk factors for contrast-induced nephropathy.The Impact of Remote Ischemic Pre-Conditioning on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Angioplasty: A Double-Blind Randomized Clinical Trial.Risk factors and therapy strategies for contrast-induced nephropathy.Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.

P2860

Q26801447-3F275F70-12F7-4228-9045-18D6AF4F8231 Q26864323-09F27203-63DD-4FEC-8CE7-2C009EB5E37E Q28270013-1873BCB3-99E9-40C3-B470-7C40DF1CD7D1 Q28680679-5E0D68A1-6739-4B55-833E-5FEAE449DA75 Q30439077-841E9D65-8768-443E-A3F7-D85A13C4925C Q30487828-C0651A10-5E45-4F98-8CF4-322360563A49 Q30878953-5C989D16-4867-41E6-88A7-7C467F00544A Q33383007-2318BB72-351D-476F-B7EF-23149FD73129 Q33578171-7E2E45FC-3713-436C-8E6B-4FA5C01486DB Q33599720-FE65D2BC-B34A-407D-9E46-1AA6F43385FD Q33685017-31DE0387-9D7F-48C1-B67D-0F8A197A781A Q33729371-C94EE058-69F6-49BD-B388-04E20952A9DD Q34005294-26AA864E-FA6B-4863-B1BA-63503E15F256 Q34142374-EDEF9748-4940-43D1-BE7D-BAF5C71536D0 Q34155673-EC7C283F-DAFA-46D9-9466-D5F550EA0F39 Q34269645-26E73A9D-481A-4602-AB8B-226F1F2F7D86 Q34428322-8E9FFEE2-4B45-49DE-A4C1-5BE8E51AEC54 Q34437133-EA9142B2-2D1F-48E2-8126-C677DE6BCD2D Q34438015-E8C7718A-D4B3-43C7-9FE9-45A737BD8037 Q34467009-D06F5E68-6D7F-4C8B-ABAE-41E9B16E1D43 Q34574872-B907AA7B-1388-40AF-9A14-F001B8D16CF2 Q34816125-3BF96A33-61B5-469F-B381-3B86FB1D58D4 Q35048384-70C086E1-A837-4517-9D08-38E0A94BAB22 Q35081498-94225684-6DF1-4A77-B76B-2B5E09D21DF9 Q35083828-A28352CD-07B7-4B2C-BB76-290AF400D9B4 Q35193141-33132205-7920-4DCA-805A-D041B5CDE0FC Q35567418-0863798D-D5D9-4368-8DC3-6CEDEF6A489C Q35576454-F3A18B5A-59C8-4633-9C67-07AD43F73EF6 Q35666177-17DDE1C6-122C-406C-A147-EA1ABAD7125D Q35930002-A7D20D7E-1AC5-434E-BEF2-717239D45A94 Q36009044-DC1BA4F9-DCD9-4470-93C8-D17C008FE08F Q36085790-CA6AA5B8-04E5-4B2D-9462-9854AA40EB14 Q36159523-8CDC2E10-A557-4AB6-B645-8F96D7035BE7 Q36182190-35D96A12-7D3B-41F3-B191-D1699D354D39 Q36183555-6345EC06-A25E-4A6A-9322-0EC7B0750DCF Q36481450-5FE2F9C8-18CD-43A5-A82B-6D9C9D06ABDF Q36497957-EADE3086-F008-45E3-9390-4CFFE0E57F3A Q36529372-8ABA12B2-3372-4721-83BE-3637B92449D5 Q36626647-1C5B76AA-8767-4AB3-AD11-3B518708440B Q36680376-C5142796-A0DE-40A9-AA34-FCF973F96CEA

P2860

Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.

http://www.wikidata.org/entity/Q45201786

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Contrast-induced nephropathy a ...... ase and hemodynamic variables.

@en

Contrast-induced nephropathy a ...... ase and hemodynamic variables.

@nl

type

label

Contrast-induced nephropathy a ...... ase and hemodynamic variables.

@en

Contrast-induced nephropathy a ...... ase and hemodynamic variables.

@nl

prefLabel

Contrast-induced nephropathy a ...... ase and hemodynamic variables.

@en

Contrast-induced nephropathy a ...... ase and hemodynamic variables.

@nl

P1433

Q45201786-EA08B397-C295-4347-AE57-3F8AEF494867

P1476

Q45201786-8FFA7E65-8A0E-4DD6-BDDF-9FCC60EFDABD

P2093

Q45201786-2908829B-D49C-4774-8ACF-BBF06F1C7D3C

Q45201786-36E106A5-74FB-40E5-B494-4152D6682420

Q45201786-72659CF3-4C0F-484D-B2EA-D8F731570690

Q45201786-800FB491-8AB1-4CDF-9287-2935BAC9B67C

Q45201786-86BE0816-9568-431A-9C46-23E08031A867

Q45201786-B274405B-ED28-4A30-B022-D70E31F8B997

Q45201786-B52EEF06-038B-4BBE-B3CC-386D51765DA4

Q45201786-CB617E71-7FFA-4540-A303-1FA7CF0DCE0B

Q45201786-E5AEE494-119C-468B-ABD4-9534DB4D349B

Q45201786-FEFAD483-5384-413A-9685-603979124BA2

P304

Q45201786-EEC7984E-E099-476B-9128-92648CE812C4

P31

Q45201786-7CE167E8-D465-44AA-A900-C47316AF494C

P356

Q45201786-80645E72-C8E2-42AA-BE4C-165100C1FAE0

P407

Q45201786-E445DF22-6749-4878-B691-DD98DFF49A9E

P433

Q45201786-DE6B38BD-BA25-4994-AB44-581C7BCD643C

P478

Q45201786-5627AEEB-03E0-4502-8FEF-6D3B5D11F926

P50

Q45201786-097F5FB7-1FF8-4FB6-8A88-184FD13A57A5

Q45201786-0E77FC17-82E1-4C5E-8C8A-46D99D5DF1AF

P577

Q45201786-B9143A18-3930-41F0-B9D2-1FB65543DD40

P5875

Q45201786-013A037E-D006-4B09-A4C3-B8B08066EB2E

P698

Q45201786-73DECCD1-4C78-45ED-ABAE-E909C0B8DA04

P921

Q45201786-4E83E5EB-7B40-4D87-AE4E-87D8E2E08670

P356

J.AMJCARD.2004.08.056

P1433

American Journal of Cardiology

P1476

Contrast-induced nephropathy a ...... ase and hemodynamic variables.

@en

P2093

Alexandra J Lansky

http://www.w3.org/2001/XMLSchema#string

Eugenia Nikolsky

http://www.w3.org/2001/XMLSchema#string

Eve D Aymong

http://www.w3.org/2001/XMLSchema#string

Gary S Mintz

http://www.w3.org/2001/XMLSchema#string

Gregg W Stone

http://www.w3.org/2001/XMLSchema#string

Ioannis Iakovou

http://www.w3.org/2001/XMLSchema#string

Issam Moussa

http://www.w3.org/2001/XMLSchema#string

Jeffrey W Moses

http://www.w3.org/2001/XMLSchema#string

Martin B Leon

http://www.w3.org/2001/XMLSchema#string

Nicholas N Kipshidze

http://www.w3.org/2001/XMLSchema#string

P304

13-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJCARD.2004.08.056

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

George D Dangas

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8112081

http://www.w3.org/2001/XMLSchema#string

P698

15619387

http://www.w3.org/2001/XMLSchema#string

P921